Compound ID | 1254
Class: PolC inhibitor (thiadiazole urea derived)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Gram-positive antibacterial drug. |
| Institute where first reported: | Crestone, Inc., Boulder, United States, Colorado State University, Fort Collins, United States, SJ Brickner Consulting LLC, Ledyard, United States |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |